G.F.C. Green Fields Capital (XTAE:GFC-M) EBIT: ₪34.79 Mil (TTM As of Dec. 2025)


XTAE:GFC-M G.F.C. Green Fields Capital Ltd XTAE:GFC-M
20 GF Score
Price ₪16.03
! 2 Warning Signs
View Full Analysis

What is G.F.C. Green Fields Capital EBIT?

G.F.C. Green Fields Capital XTAE:GFC-M 20 EBIT is ₪34.79 Mil as of Dec. 2025. GuruFocus rates XTAE:GFC-M with a GF Score™ of 20/100. The stock has 2 warning signs investors should review.

G.F.C. Green Fields Capital's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was ₪10.34 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was ₪34.79 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. G.F.C. Green Fields Capital's annualized ROC % for the quarter that ended in Dec. 2025 was -0.34%. G.F.C. Green Fields Capital's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 827,120.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. G.F.C. Green Fields Capital's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -76.36%.

G.F.C. Green Fields Capital  (XTAE:GFC-M) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

G.F.C. Green Fields Capital's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-1.842 * ( 1 - 7.6% )/( (589.935 + 399.319)/ 2 )
=-1.702008/494.627
=-0.34 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=788.264 - 10.735 - ( 773.631 - max(0, 586.526 - 774.12+773.631))
=589.935

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=605.966 - 5.441 - ( 593.861 - max(0, 392.784 - 593.99+593.861))
=399.319

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

G.F.C. Green Fields Capital's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=20.678/( ( (0.003 + max(-586.037, 0)) + (0.002 + max(-5.649, 0)) )/ 2 )
=20.678/( ( 0.003 + 0.002 )/ 2 )
=20.678/0.0025
=827,120.00 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.489 + 0 + 0) - (10.735 + 0 + 575.791)
=-586.037

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.0070000000000618) - (5.441 + 0 + 0.21500000000003)
=-5.649

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

G.F.C. Green Fields Capital's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=34.793/-45.566
=-76.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G.F.C. Green Fields Capital EBIT Related Terms

G.F.C. Green Fields Capital EBIT Historical Data

* Premium members only.

The historical data trend for G.F.C. Green Fields Capital's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G.F.C. Green Fields Capital EBIT Chart

G.F.C. Green Fields Capital Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.63 1.76 24.22 35.22 34.79

G.F.C. Green Fields Capital Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.48 16.44 18.78 24.45 10.34

XTAE:GFC-M vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, G.F.C. Green Fields Capital's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.F.C. Green Fields Capital EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.F.C. Green Fields Capital's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where G.F.C. Green Fields Capital's EV-to-EBIT falls into.


XTAE:GFC-M
20GF Score
G.F.C. Green Fields Capital Ltd XTAE:GFC-M
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

G.F.C. Green Fields Capital EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪34.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₪34.79 Mil mean?
G.F.C. Green Fields Capital (XTAE:GFC-M) has a EBIT of ₪34.79 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on G.F.C. Green Fields Capital.
Is G.F.C. Green Fields Capital's EBIT too high?
G.F.C. Green Fields Capital's current EBIT is ₪34.79 Mil. Overall, G.F.C. Green Fields Capital has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does G.F.C. Green Fields Capital's EBIT compare to VRTX and REGN?
G.F.C. Green Fields Capital's EBIT of ₪34.79 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on G.F.C. Green Fields Capital. G.F.C. Green Fields Capital's current EBIT is ₪34.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G.F.C. Green Fields Capital stock overvalued right now?
G.F.C. Green Fields Capital (XTAE:GFC-M) has a current EBIT of ₪34.79 Mil. The current EBIT is ₪34.79 Mil. G.F.C. Green Fields Capital's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For G.F.C. Green Fields Capital (XTAE:GFC-M), the current EBIT is ₪34.79 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

G.F.C. Green Fields Capital Business Description

Address 7 Bnei Brak, Masada, Ramat Gan, ISR, 5126112
G.F.C. Green Fields Capital Ltd develops improved plant traits using genes called microRNAs for the agriculture and biofuel industries. It is engaged in the identification of genes for improvement in plant cultivation.
20GF Score

Get the complete analysis for XTAE:GFC-M

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪16.03
Price